Skip to main content
I

Igraine plc — Investor Relations & Filings

Ticker · KINGI ISIN · GB00BM9CKV18 LEI · 213800VX2NIA6TZN3I39 Aquis Stock Exchange Financial and insurance activities
Open in API
Filings indexed 97 across all filing types
Latest filing 2025-09-02 Major Shareholding Noti…
Country GB United Kingdom
Listing Aquis Stock Exchange KINGI

About Igraine plc

https://igraineplc.com/

Igraine plc is an investment company that has shifted its strategy to focus on two primary areas: implementing an Ethereum-based treasury management policy and investing in technologies that support the global energy transition. The company's investment portfolio targets high-growth opportunities, particularly in battery storage, renewable energy solutions, and electric vehicle (EV) charging infrastructure. This dual approach aims to build a diversified platform by combining disciplined digital asset treasury management with exposure to technology-driven sectors. Previously, the company's focus included investments in the healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
Igraine Plc - Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the regulatory standard in the UK for disclosing significant changes in share ownership. It explicitly details the issuer (Igraine Plc), the person subject to the notification (Stephen Hill), and the percentage of voting rights held (6.48%). This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-09-02 English
Igraine Plc - Investee Update: Collaboration Agreement with Homerun Resources Inc.
Regulatory Filings Classification · 1% confidence The document is a press release issued via a Regulatory Information Service (RIS) announcing a new collaboration agreement between Igraine Plc and Homerun Resources Inc. It details the nature of the partnership, the strategic goals, and quotes from company leadership. As it is a general corporate announcement regarding business operations and strategic partnerships that does not fit into specific categories like M&A (which usually implies a takeover or merger) or financial reporting, it is classified as a general regulatory filing.
2025-08-05 English
Igraine Plc - Investee Update: Fixit Medical Ltd
Board/Management Information Classification · 1% confidence The document is an announcement by Igraine Plc regarding an update on its investee company, Fixit Medical Ltd. The key events announced are the 'Appointment of Non-Executive Director' (Professor Chris Nutting) and a 'Strategic Investment' made by this new director into the investee company. This type of announcement, detailing changes in senior personnel (Board appointment) and related share transactions/investments by management/directors of an investee company, most closely aligns with the 'Board/Management Information' category (MANG). While there is an investment, the primary focus is the board change and the associated commentary, rather than a general capital raise (CAP) or insider trading report (DIRS) concerning Igraine's own directors. Since it is an announcement published via a RIS, it is a regulatory disclosure, but MANG is the most specific fit for the content.
2025-07-16 English
Igraine Plc - Financial Statements for the Year Ended 31 December 2024
Audit Report / Information Classification · 1% confidence The document is explicitly titled "Igraine Plc - Financial Statements for the Year Ended 31 December 2024". It contains detailed sections like 'REVIEW OF BUSINESS', 'INVESTEE COMPANY UPDATES', 'POST-YEAR END REVIEW', and includes full financial tables such as the 'Statement of Profit or Loss For the year ended 31 December 2024' and the 'Statement of Financial Position As at 31 December 2024'. Furthermore, it includes an 'Extract from the audit report' mentioning 'Material uncertainty related to going concern'. The combination of comprehensive financial statements covering a full fiscal year (31 December 2024) and the inclusion of audit commentary strongly indicates this is the company's official Annual Report, which corresponds to the SEC's 10-K filing structure for comprehensive annual reporting, even if this specific filing is for the Aquis Growth Market. FY 2024
2025-06-27 English
Igraine Plc - Investee Update: Fixit Medical Ltd
Regulatory Filings Classification · 1% confidence The document is an update provided by Igraine Plc regarding its investee company, Fixit Medical Ltd (now Cingo Technologies). It details strategic collaborations, manufacturing milestones, progress toward FDA/CE regulatory submissions, and funding applications. The text explicitly states that the information constitutes 'INSIDE INFORMATION' under MAR and is being published 'VIA A REGULATORY INFORMATION SERVICE ("RIS")'. This structure—an update on an investee company, framed as inside information released via an RIS—is characteristic of a general regulatory announcement rather than a specific periodic report (like 10-K or IR) or a formal earnings release (ER). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or CAP, the most appropriate fallback category is Regulatory Filings (RNS). The document length (5809 chars) is substantial enough that it is not merely an RPA announcing a separate report, but the report itself containing the update.
2025-06-23 English
Igraine Plc - Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their interest in a company crosses specific voting rights thresholds. This aligns perfectly with the definition of a 'Major Shareholding Notification' (MRQ).
2025-02-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.